Topoisomerase II trapping agent teniposide induces apoptosis and G2/M or S phase arrest of oral squamous cell carcinoma
2006

Effects of Teniposide on Oral Cancer Cells

publication Evidence: moderate

Author Information

Author(s): Li Jinzhong, Chen Wantao, Zhang Ping, Li Ningyi

Primary Institution: Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University

Hypothesis

The study aims to identify the effect of VM-26 against oral squamous cell carcinoma in vitro.

Conclusion

VM-26 could significantly induce apoptosis of oral squamous cell carcinoma and inhibit cell growth.

Supporting Evidence

  • The IC50 of VM-26 against Tca8113 cells was 0.35 mg/l.
  • Apoptotic rate of Tca8113 cells incubated with 5.0 mg/l of VM-26 for 72 hours was 81.67%.
  • Cells treated with 0.15 mg/l of VM-26 showed significant G2/M phase arrest.

Takeaway

VM-26 is a drug that can help kill cancer cells in the mouth by making them die and stopping them from growing.

Methodology

The study used the Tca8113 cell line and assessed the effects of VM-26 on cell growth and apoptosis through various assays including MTT and flow cytometry.

Limitations

The study primarily focuses on in vitro results, which may not fully represent in vivo effects.

Digital Object Identifier (DOI)

10.1186/1477-7819-4-41

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication